(42) use CXCR4 antagonists to inhibit GH secretion and also inhibit proliferation of GH-secreting pituitary tumor cells, which indicates targeting CXCL12 might be potentially also useful to NF-PitNETs. The gene discussed is CXCR4; the disease is pituitary tumor.